Congratulations! You have successfully installed your theme. However, it may look incomplete at this moment. Do NOT panic as you simply need to configure your Theme Options. Please go through the Theme Options completely and select an option for each setting. After that, you're site will be ready for the world!

Home » Posts tagged with » PD-(L)1 inhibitor
FDA approves BeiGene’s TEVIMBRA for esophageal cancer treatment

FDA approves BeiGene’s TEVIMBRA for esophageal cancer treatment

In a notable advancement in the oncology sector, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a globally recognized oncology company, has received approval from the U.S. Food and Drug Administration (FDA) for TEVIMBRA (tislelizumab-jsgr). This approval marks a significant milestone for TEVIMBRA as a monotherapy in the treatment of adult patients with unresectable or […]

March 18, 2024Comments Off on FDA approves BeiGene’s TEVIMBRA for esophageal cancer treatmentRead More